戻る Agenda
Value-Based Conversations with Payers: Issues, Opportunities, and Barriers
Session Chair(s)
Richard Gliklich, MD
Founder
OM1, United States
This session will review the drivers for value-based contracting including risk taking by providers and payers, and the barriers. These barriers include FDA labeling decisions, communication of unapproved uses, Medicaid best price and anti-kickback concerns.
Learning Objective : Describe the business, regulatory, and legal considerations surrounding value-based contracting conversations with payers.
Speaker(s)
Aligning Stakeholder Needs for Value-Based Contracts
Richard Gliklich, MD
OM1, United States
Founder
Manufacturer Perspective
Robert Duffield, JD
Novo Nordisk A/S, United States
Counsel
Payer Perspective
Jim Clement, MHA
Aetna, Inc., United States
Executive Director, Cost of Care and Supply Chain Strategy